These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4274244)

  • 1. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat.
    Kilbey MM; Moore JW
    Psychopharmacologia; 1973 Jul; 31(2):157-66. PubMed ID: 4737311
    [No Abstract]   [Full Text] [Related]  

  • 3. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC; Pedemonte WA; Whalley C; Mosnaim AD; Vazquez AJ
    Life Sci; 1974 Jan; 14(1):149-56. PubMed ID: 4810493
    [No Abstract]   [Full Text] [Related]  

  • 4. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 6. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
    Green AR; Youdim MB; Grahame-Smith DG
    Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical correlates in mouse-killing behavior of the rat: brain acetylcholine and acetylcholinesterase after administration of delta9-tetrahydrocannabinol.
    Yoshimura H; Fujiwara M; Ueki S
    Brain Res; 1974 Dec; 81(3):567-70. PubMed ID: 4474050
    [No Abstract]   [Full Text] [Related]  

  • 8. Attack behaviour in mice inhibited by -9-tetrahydrocannabinol.
    Kilbey MM; Fritchie GE; McLendon DM; Johnson KM
    Nature; 1972 Aug; 238(5365):463-5. PubMed ID: 4561858
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 10. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of (-) 9 -trans-tetrahydrocannabinol and its selectivity in several models of aggressive behavior.
    Dubinsky B; Robichaud RC; Goldberg ME
    Pharmacology; 1973; 9(4):204-16. PubMed ID: 4736761
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms.
    Robichaud RC; Hefner MA; Anderson JE; Goldberg ME
    Pharmacology; 1973; 10(1):1-11. PubMed ID: 4751537
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 15. Mouse-killing behavior (muricide) induced by delta 9-tetrahydrocannabinol in the rat.
    Ueki S; Fujiwara M; Ogawa N
    Physiol Behav; 1972 Oct; 9(4):585-7. PubMed ID: 4677621
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.
    Sabelli HC; Vazquez AJ; Flavin D
    Psychopharmacologia; 1975 May; 42(2):117-25. PubMed ID: 1161972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
    Sofia RD; Kubena RK; Barry H
    Psychopharmacologia; 1973 Jul; 31(2):121-30. PubMed ID: 4722206
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta9-tetrahydrocannabinol and aggressive behavior in rats.
    Miczek KA; Barry H
    Behav Biol; 1974 Jun; 11(2):261-7. PubMed ID: 4858807
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):83-98. PubMed ID: 4280020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.